Cargando…

Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa

Pseudomonas aeruginosa (PA) is a leading cause of hospital-acquired and ventilator-associated pneumonia. The multidrug-resistance (MDR) rate of PA is increasing making the management of PA a global challenge. Messenger RNA (mRNA) vaccines represent the most promising alternative to conventional vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xingyun, Liu, Cong, Rcheulishvili, Nino, Papukashvili, Dimitri, Xie, Fengfei, Zhao, Jiao, Hu, Xing, Yu, Kaiwei, Yang, Nuo, Pan, Xuehua, Liu, Xueyan, Wang, Peng George, He, Yunjiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209580/ https://www.ncbi.nlm.nih.gov/pubmed/37231060 http://dx.doi.org/10.1038/s41541-023-00672-4

Ejemplares similares

Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020)

Conserved OprF as a Selective Immunogen against Pseudomonas aeruginosa
por: Kazemi Moghaddam, Ehsan, et al.
Publicado: (2017)

Association of OprF mutant and disturbance of biofilm and pyocyanin virulence in pseudomonas aeruginosa
por: Bukhari, Sarah I., et al.
Publicado: (2020)

Factors Affecting the Folding of Pseudomonas aeruginosa OprF Porin into the One-Domain Open Conformer
por: Sugawara, Etsuko, et al.
Publicado: (2010)

Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes
por: Mayeux, Géraldine, et al.
Publicado: (2021)

OprF functions as a latch to direct Outer Membrane Vesicle release in Pseudomonas aeruginosa
por: Mathur, Shrestha, et al.
Publicado: (2023)

Pseudomonas aeruginosa OprF plays a role in resistance to macrophage clearance during acute infection
por: Moussouni, Malika, et al.
Publicado: (2021)

Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023)

Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization
por: Peluso, Lucia, et al.
Publicado: (2010)

Specific Association of Lectin LecB with the Surface of Pseudomonas aeruginosa: Role of Outer Membrane Protein OprF
por: Funken, Horst, et al.
Publicado: (2012)

OprF impacts Pseudomonas aeruginosa biofilm matrix eDNA levels in a nutrient-dependent manner
por: Cassin, Erin K., et al.
Publicado: (2023)

OprF Impacts Pseudomonas aeruginosa Biofilm Matrix eDNA Levels in a Nutrient-Dependent Manner
por: Cassin, Erin K., et al.
Publicado: (2023)

Immunopotentiating properties of chimeric OprF-OprI-PopB protein against Pseudomonas aeruginosa PAO1 in the infected burned rat model
por: Sabzehali, Fattaneh, et al.
Publicado: (2022)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
por: Liu, Cong, et al.
Publicado: (2022)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
por: Papukashvili, Dimitri, et al.
Publicado: (2022)

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017)

The absence of the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in c-di-GMP level
por: Bouffartigues, Emeline, et al.
Publicado: (2015)

Cyclic-di-GMP and oprF Are Involved in the Response of Pseudomonas aeruginosa to Substrate Material Stiffness during Attachment on Polydimethylsiloxane (PDMS)
por: Song, Fangchao, et al.
Publicado: (2018)

Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
por: Papukashvili, Dimitri, et al.
Publicado: (2021)

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022)

Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and oprF mutants
por: Garai, Preeti, et al.
Publicado: (2019)

Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine
por: Rcheulishvili, Nino, et al.
Publicado: (2023)

Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs– focus on the bigger picture
por: Rcheulishvili, Nino, et al.
Publicado: (2022)

Self-Amplifying RNA Approach for Protein Replacement Therapy
por: Papukashvili, Dimitri, et al.
Publicado: (2022)

Correction: Papukashvili et al. “Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO” Nutrients, 2020, 12, 184
por: Papukashvili, Dimitri, et al.
Publicado: (2020)

Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO
por: Papukashvili, Dimitri, et al.
Publicado: (2020)

Beneficial Impact of Semicarbazide-Sensitive Amine Oxidase Inhibition on the Potential Cytotoxicity of Creatine Supplementation in Type 2 Diabetes Mellitus
por: Papukashvili, Dimitri, et al.
Publicado: (2020)

Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
por: Wan, Chuang, et al.
Publicado: (2019)

Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
por: Sundin, Charlotta, et al.
Publicado: (2021)

Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
por: Horna, Gertrudis, et al.
Publicado: (2018)

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
por: Faure, Karine, et al.
Publicado: (2003)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections
por: Asadi Karam, Mohammad Reza, et al.
Publicado: (2022)

PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon
por: Kundracik, Emma, et al.
Publicado: (2022)

Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses
por: Rcheulishvili, Nino, et al.
Publicado: (2023)

Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
por: Jiang, Mingzi, et al.
Publicado: (2014)

A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
por: Aguilera-Herce, Julia, et al.
Publicado: (2019)

Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
por: Wang, Ying, et al.
Publicado: (2021)

Immune Efficacy of different immunization doses of divalent combination DNA vaccine pOPRL+pOPRF of Pseudomonas aeruginosa
por: GONG, Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kubs4f6d4a8m4ko40rkv0t5pif